3 Asian Stocks Estimated To Be Trading At Discounts Of Up To 37%

Simply Wall St

Mon, December 22, 2025 at 11:37 PM EST 4 min read

Amid recent developments in Asia’s financial landscape, including the Bank of Japan raising its benchmark interest rate to a 30-year high and mixed signals from China’s economic indicators, investors are keenly observing opportunities for value in the region. In this context, identifying stocks that are trading at a discount can be particularly appealing, as they may offer potential upside when market conditions stabilize or improve.

Click here to see the full list of 271 stocks from our Undervalued Asian Stocks Based On Cash Flows screener.

Let’s uncover some gems from our specialized screener.

Overview: Consun Pharmaceutical Group Limited focuses on the research, development, manufacturing, and sale of Chinese medicines and medical contrast medium products in the People’s Republic of China, with a market cap of HK$13.58 billion.

Operations: The company’s revenue is primarily derived from the Consun Pharmaceutical Segment, contributing CN¥2.82 billion, and the Yulin Pharmaceutical Segment, which accounts for CN¥469.22 million.

Estimated Discount To Fair Value: 37%

Consun Pharmaceutical Group is trading at HK$16.15, significantly below its estimated fair value of HK$25.63, suggesting it may be undervalued based on cash flows. Despite an unstable dividend track record, the company shows strong relative value compared to industry peers and has experienced a 20.6% earnings growth over the past year. Earnings are forecast to grow at 12.5% annually, outpacing the Hong Kong market’s growth rate of 12.1%.

• In light of our recent growth report, it seems possible that Consun Pharmaceutical Group’s financial performance will exceed current levels.

• Delve into the full analysis health report here for a deeper understanding of Consun Pharmaceutical Group.

Overview: Rayhoo Motor Dies Co.,Ltd. operates in the automobile manufacturing equipment and lightweight parts sectors both in China and globally, with a market cap of CN¥7.68 billion.